Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Not Confirmed
Not Confirmed
26-27 September, 2024
Oligo Chemistry & Ther...Oligo Chemistry & Therapeutics 2024
Not Confirmed
Not Confirmed
27 September, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Industry Trade Show
Not Confirmed
26-27 September, 2024
Oligo Chemistry & Ther...Oligo Chemistry & Therapeutics 2024
Webinar
Not Confirmed
27 September, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
30 Oct 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sebela-womens-health-announces-further-positive-data-from-the-pivotal-phase-3-study-of-the-investigational-copper-175-mm-intra-uterine-device-iud-301971779.html
22 Jun 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/fda-approves-sebela-pharmaceuticals-suflave-a-new-colonoscopy-preparation-that-tastes-similar-to-a-sports-drink-301858251.html
21 Mar 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/sebela-womens-health-shares-findings-from-a-real-world-cost-comparison-of-hormonal-and-non-hormonal-iud-use-among-privately-insured-individuals-in-the-us-301777224.html
27 Feb 2023
// Paul Schloesser ENDPTS
https://endpts.com/uk-biotech-hands-off-mid-stage-c-difficile-drug-in-up-to-570m-deal/
15 Nov 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/sebela-pharmaceuticals-announces-new-division-named-sebela-womens-health-301678785.html
28 Oct 2022
// PRNEWSWIRE
https://www.prnewswire.com/news-releases/sebela-pharmaceuticals-acquires-exclusive-licensing-rights-to-develop-and-commercialize-tegoprazan-in-the-us-and-canada-301661796.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?